You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
31 March 2026 - Cell-free DNA testing company Natera Inc (NASDAQ:NTRA) on Tuesday reported publication of a prospective study in Clinical Cancer Research demonstrating that its Signatera molecular residual disease (MRD) test can help identify older p...
31 March 2026 - Danish pharmaceutical company ALK-Abelló A/S (ALK) (CPH:ALK-B) announced on Tuesday that the European Commission has granted marketing authorisation for EURneffy 1 mg, enabling a needle-free adrenaline treatment for anaphylaxis...
31 March 2026 - Belgian biotechnology company Galapagos NV (Euronext Brussels:GLPG) (NASDAQ:GLPG) announced on Tuesday that it has entered into a binding agreement with US biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) to collaborate on ...
31 March 2026 - Delonix Bioworks, a clinical-stage biotechnology company developing genetically engineered bacterial vaccines, announced on Monday the initiation of first-in-human (FIH) dosing in a Phase 1 clinical trial of DX-104.DX-104 is an innova...
31 March 2026 - Pharmaceutical company Hengrui Pharma and Braveheart Bio, a late clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions, on Monday reported results from a multi-centre...
31 March 2026 - Chinese biopharmaceutical company Innovent Biologics Inc (HKEX:01801) announced on Monday that its US partner Ollin Biosciences has reported final, 20-week study completion data from its randomised, head-to-head Phase 1b JADE clinical...